Last reviewed · How we verify

Pentoxifylline with Vitamin E

Altamash Institute of Dental Medicine · FDA-approved active Small molecule Quality 5/100

Pentoxifylline with Vitamin E is a Small molecule drug developed by Altamash Institute of Dental Medicine. It is currently FDA-approved.

At a glance

Generic namePentoxifylline with Vitamin E
SponsorAltamash Institute of Dental Medicine
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Pentoxifylline with Vitamin E

What is Pentoxifylline with Vitamin E?

Pentoxifylline with Vitamin E is a Small molecule drug developed by Altamash Institute of Dental Medicine.

Who makes Pentoxifylline with Vitamin E?

Pentoxifylline with Vitamin E is developed and marketed by Altamash Institute of Dental Medicine (see full Altamash Institute of Dental Medicine pipeline at /company/altamash-institute-of-dental-medicine).

What development phase is Pentoxifylline with Vitamin E in?

Pentoxifylline with Vitamin E is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing